To uncover the molecular mechanism underlying abnormal activation of QSOX2, we analyzed three NSCLC expression profile databases from GEO, one of which contained NSCLC cell line expression data used to avoid the expression profiles of stromal cell components biasing the analysis results. The gene discussed is QSOX2; the disease is non-small cell lung carcinoma.